OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings
Ahmed Fnaiche, Léa Mélin, Narjara González Suárez, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 95, pp. 129488-129488
Closed Access | Times Cited: 6
Ahmed Fnaiche, Léa Mélin, Narjara González Suárez, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 95, pp. 129488-129488
Closed Access | Times Cited: 6
Showing 6 citing articles:
Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics
Na Li, Yunhe Liu, Ji Yuan Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116694-116694
Closed Access | Times Cited: 4
Na Li, Yunhe Liu, Ji Yuan Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116694-116694
Closed Access | Times Cited: 4
Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells
Marie‐Eve Roy, C Veilleux, Alexis Paquin, et al.
Anti-Cancer Drugs (2024)
Open Access | Times Cited: 3
Marie‐Eve Roy, C Veilleux, Alexis Paquin, et al.
Anti-Cancer Drugs (2024)
Open Access | Times Cited: 3
Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration
Ahmed Fnaiche, Hwai‐Chien Chan, Alexis Paquin, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1746-1753
Closed Access | Times Cited: 7
Ahmed Fnaiche, Hwai‐Chien Chan, Alexis Paquin, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1746-1753
Closed Access | Times Cited: 7
Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure–activity relationship
E Haripriya, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Molecular Diversity (2024)
Closed Access
E Haripriya, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Molecular Diversity (2024)
Closed Access
TEAD-targeting small molecules induce a cofactor switch to regulate the Hippo pathway
Alissa D. Guarnaccia, Thijs J. Hagenbeek, Wendy Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alissa D. Guarnaccia, Thijs J. Hagenbeek, Wendy Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A Role for the Hippo/YAP1 Pathway in the Regulation of In Vitro Vasculogenic Mimicry in Glioblastoma Cells
Marie‐Eve Roy, Rahil Elimam, Alain Zgheib, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 24
Open Access
Marie‐Eve Roy, Rahil Elimam, Alain Zgheib, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 24
Open Access
